Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Intellia Therapeutics Inc banner

Intellia Therapeutics Inc
NASDAQ:NTLA

Watchlist Manager
Intellia Therapeutics Inc Logo
Intellia Therapeutics Inc
NASDAQ:NTLA
Watchlist
Price: 10.9875 USD -11.1% Market Closed
Market Cap: $1.3B
Write Note Create Alert Ask AI

Intrinsic Value

The intrinsic value of one NTLA stock under the Base Case scenario is hidden USD. Compared to the current market price of 10.9875 USD, Intellia Therapeutics Inc is hidden .

Valuation Methods:
DCF Value
N/A
Relative Value
Hidden
DCF Value
N/A
Relative Value
Hidden
NTLA Intrinsic Value
HIDDEN
Show
Base Case Scenario

Valuation History
Intellia Therapeutics Inc

Intrinsic Value History
Dive into the past to invest in the future

NTLA looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether NTLA usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about NTLA?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is NTLA valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Intellia Therapeutics Inc.

Explain Valuation
Compare NTLA to

Fundamental Analysis

How do you feel about NTLA?
Bearish
Neutral
Bullish
Financials
Efficiency

Earnings Waterfall
Intellia Therapeutics Inc

Wall St
Price Targets

NTLA Price Targets Summary
Intellia Therapeutics Inc

Wall Street analysts forecast NTLA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NTLA is 23.9432 USD with a low forecast of 5.05 USD and a high forecast of 111.3 USD.

NTLA Lowest Forecast
Wall Street Target
5.05 USD
-54% Downside
NTLA Average Forecast
Wall Street Target
23.9432 USD
118% Upside
NTLA Highest Forecast
Wall Street Target
111.3 USD
913% Upside
Lowest
Price Target
5.05 USD
54% Downside
Average
Price Target
23.9432 USD
118% Upside
Highest
Price Target
111.3 USD
913% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Intellia Therapeutics Inc
does not pay dividends
Shareholder Yield
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Ownership

NTLA Insider Trading
Buy and sell transactions by insiders

NTLA News

See Also

Summary
NTLA intrinsic value, competitors valuation, and company profile.
DCF Valuation
NTLA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NTLA stock valuation using valuation multiples.
Wall Street Estimates
NTLA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NTLA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is the Intrinsic Value of one NTLA stock?

The intrinsic value of one NTLA stock under the Base Case scenario is hidden USD.

Is NTLA stock undervalued or overvalued?

Compared to the current market price of 10.9875 USD, Intellia Therapeutics Inc is hidden .

Back to Top
ALPHA SPREAD
Follow us
Join more than 315,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.